Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
modified lanolin
- Development stage
- Unknown
- Lead developer
- Altova Healthcare
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Modified lanolin is an ultra-purified, medical-grade emollient and skin protectant derived from the wool of sheep (Ovis aries). It undergoes specialized refining processes to significantly reduce the levels of free lanolin alcohols, environmental pesticides, and detergent residues, resulting in a highly hypoallergenic and biocompatible substance. Modified lanolin acts primarily as a semi-occlusive barrier and humectant when applied topically. It mimics the lipid matrix of the stratum corneum, penetrating the upper layers of the skin to replenish essential lipids, lock in moisture, and accelerate the repair of the skin's natural barrier. It is widely used in pharmaceutical and cosmetic formulations, most notably as a topical cream for soothing and healing sore, cracked nipples in breastfeeding mothers, as well as for treating diaper rash, dry skin, and minor skin irritations.
- Brand names
- Lansinoh HPAMedilanNipMomsPharmalan
- Other names
- HPA lanolinLanolin USP ModifiedModified Lanolin USPpurified lanolin
Beyond the preview
Go deeper on modified lanolin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on modified lanolin.